2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO31] Mini-Oral Session 31　Clinical Trial Facilitation Program 1（Trial in Progress）

Sat. Feb 19, 2022 8:20 AM - 9:10 AM Room 3 (Annex 2, 1F, Kyoto International Conference Center)

Chair：Tetsuya Kusumoto（Department of Gastroenterological Surgery / Clinical Research Institute Cancer Research Division），Hideo Baba（Department of Gastroenterological Surgery, Graduate School of Medical Sciences Kumamoto University）

[MO31-1] A Phase 2 Study of Datopotamab Deruxtecan in Advanced NSCLC With Actionable Genomic Alterations (TROPION-Lung05)

○Kiyotaka Yoh1, Melissa Johnson2, Alexander Spira3, Rebecca Heist4, Aaron Lisberg5, Jonathan Greenberg6, Penny Phillips6, Lan Lan6, Wen Gu6, Yong Zhang6, Jacob Sands7 (1.National Cancer Center Hospital East, Kashiwa, Japan, 2.Sarah Cannon Research Institute, Tennessee Oncology, PLLC/OneOncology, Nashville,TN/United States of America, 3.Virginia Cancer Specialists and US Oncology Research, Fairfax, VA/United States of America, 4.Massachusetts General Hospital, Boston, MA/United States of America, 5.University of California Los Angeles, Los Angeles, CA/United States of America, 6.Daiichi Sankyo, Inc., Basking Ridge, NJ/United States of America, 7.Dana-Farber Cancer Institute, Boston, MA/United States of America)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password